Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Multicenter Study of the Safety, Tolerability, and Pharmacokinetics of Different Doses of Stimotimagene Copolymerplasmid at Patients With Advanced-stage Solid Tumors With Cymeven® (Ganciclovir) Infusions

NCT05578820 is registered in ClinicalTrials.gov with Gene Surgery LLC as lead sponsor.

NCT NCT05578820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05578820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Multicenter Study of the Safety, Tolerability, and Pharmacokinetics of Different Doses of Stimotimagene Copolymerplasmid at Patients With Advanced-stage Solid Tumors With Cymeven® (Ganciclovir) Infusions
Lead sponsor
Gene Surgery LLC
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2022
Completion date
April 11, 2024
Enrollment
21 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anus neoplasms, breast neoplasms, melanoma, penile neoplasms, sarcoma, squamous cell carcinoma of head and neck, uterine cervical neoplasms, vulvar neoplasms